A phase 1b/2 study evaluating the activity of tinengotinib in combination with androgen receptor pathway inhibitors (ARPIs) in patients with metastatic castration resistant prostate cancer (mCRPC) Meeting Abstract


Authors: Abida, W.; Chen, Y.; McHugh, D. J.; Morris, M. J.; Wu, F.; Peng, P.; Hennessy, K.; Wang, H.; Fan, J.; Zaidi, S.
Abstract Title: A phase 1b/2 study evaluating the activity of tinengotinib in combination with androgen receptor pathway inhibitors (ARPIs) in patients with metastatic castration resistant prostate cancer (mCRPC)
Meeting Title: 2025 ASCO Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 43
Issue: 5 Suppl.
Meeting Dates: 2025 Feb 13-15
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2025-02-10
Language: English
ACCESSION: WOS:001454810200007
DOI: 10.1200/JCO.2025.43.5_suppl.TPS290
PROVIDER: wos
Notes: Meeting Abstract: TPS290 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Morris
    582 Morris
  2. Yu Chen
    134 Chen
  3. Wassim Abida
    157 Abida
  4. Deaglan Joseph McHugh
    45 McHugh
  5. Samir Zaidi
    27 Zaidi